A dose of the Pfizer-BioNTech vaccine is 95.6% effective.
Fizer and BioNTech
The third dose of the COVID-19 vaccine is 95.6% effective in combating symptomatic disease.
Where she praised a joint statement issued by Pfizer and BioNTech: The third dose of the vaccine against COVID-19 is 95.6% effective in combating symptoms of the disease and has shown high safety,
According to clinical trials involving 10,000 people over the age of 16, Oman TV News said in a statement.